PROCEPT BioRobotics Corp (PRCT) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US74276L1052
PROCEPT BioRobotics Corp financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 308.05 m USD |
| Gross profit | 196.23 m USD |
| Operating income | -103.86 m USD |
| EBIT | -104.02 m USD |
| Net income | -95.57 m USD |
| Diluted EPS – continuing operations | -1.72 USD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About PROCEPT BioRobotics Corp
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
More stocks
- FOCI Fiber Optic Communications (3363.TWO)
- Digital Turbine, Inc. (APPS)
- Edinburgh Worldwide Investment Trust PLC (EWI.L)
- Shandong Oriental Ocean Sci-Tech Co Ltd (002086.SZ)
- HERITAGE FINANCIAL CORP /WA/ (HFWA)
- NABORS INDUSTRIES LTD (NBR)
- Naturenergie Holding AG (NEAG.SW)
- Jiangsu Bide Science and Technology Co. Ltd. (605298.SS)
- Creades publ AB (CRED A.ST)
- MBB (MBB.DE)
- MARINEMAX INC (HZO)
- Jiangsu Hengshun Vinegar-Industry Co Ltd (600305.SS)
Not investment advice. All data without warranty, price as of 05.11.2026. Details in the risk notice.